Effective April 19, 2022: Implementation of colonoscopy waitlist reduction project and new fecal occult blood test (FOBT) requisition form.
In support of reducing the endoscopy waitlist, ColonCheck CancerCare Manitoba will be distributing fecal immunochemical tests (FIT) to consenting eligible patients currently on the elective colonoscopy waitlist. This includes patients at average risk and selected patients at increased risk due to family history or surveillance of prior low-risk adenomas. This project provides an interim option for FIT until the transition from gFOBT to full FIT implementation has occurred.
Healthcare Providers can access FOBTs for their patients using the FOBT requisition form. ColonCheck CancerCare Manitoba will supply the appropriate test kit based on the following criteria:
The following information is intended for healthcare providers whose patients are eligible for a fecal immunochemical test (FIT) for colorectal cancer (CRC) screening or surveillance:
Criteria |
Provided to Endoscopy Waitlist Clients |
Provided from Fecal Test Requisition Order Form |
Average risk screening
|
FIT | gFOBT* |
Low-increased risk screening
|
FIT | FIT |
Surveillance of low risk adenomas
|
FIT | FIT |
*This is an interim recommendation until full FIT implementation. Once full implementation occurs, it will be recommended that a FIT test be used for average risk screening.
If your patient does not meet the criteria for FIT, they will continue to receive gFOBT for average risk screening. FIT is being released earlier for select individuals to support the current endoscopy waitlist for appropriate individuals (link project announcement).
The FIT is an accurate screening test with increased sensitivity for CRC and advanced adenoma (cancer precursor) detection compared to the guaiac FOBT. The FIT is a quantitative test that is specific for human hemoglobin in the stool, and generally detects blood loss from colonic sources only. Unlike the guaiac FOBT, a FIT result is not affected by dietary factors or vitamin C.
A positive FIT result indicates that the measured hemoglobin in the sample is at or above a pre-determined threshold for positivity. Its use for average risk and some low increased risk screening, in addition to low risk adenoma surveillance, is supported by Canadian and international guidelines published by professional societies and CRC screening programs.
You can expect one of three results from a FIT kit:
ColonCheck will:
ColonCheck will:
ColonCheck will:
It is not recommended that another FIT test be performed after a positive result. Colonic bleeding may be intermittent and a repeat test with a negative result does not rule out significant colonic pathology. A positive result requires further investigation with colonoscopy.
Encourage your patients to talk to you if they have these signs and symptoms, even if their recent FIT result was negative:
If your patient has CRC symptoms, refer them for semi-urgent colonoscopy.